0000000000120704

AUTHOR

A. Romano

showing 37 related works from this author

Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content at baseline and after activation in essential hypertension

2005

researchProduct

THE DESIGN OF AN INFRASTRUCTURE FOR TECHNOLOGY TRANSFER IN SOUTHERN ITALY– ROLE OF REGIONAL INSTITUTIONS

1980

This paper coordinates and integrates the interventions of Proff. G. LO GIUDICE and A. ROMANO, included in the conference programme. It starts mainly from the socio-economical system of Southern Italy, and it consists in the following main points: - analysis of the system features to be interconnected for the development of an infrastructure for developing technological transfer; - ways of understanding the suitability of technologies for Southern Italy; - a proposal for a macro-organizational model for the development of an infrastructure aiming at the technological transfer; - pointing out the role of the “Regioni” and of the direct Government interventions in the innovative processes. (I…

GovernmentPolitical sciencemedia_common.quotation_subjectPrincipal (computer security)Technology transferRegional scienceDutymedia_common
researchProduct

Search for heavy neutrinos at the NA48/2 and NA62 experiments at CERN

2018

© The Authors, published by EDP Sciences. The NA48/2 experiment at CERN has collected large samples of charged kaons decaying into a pion and two muons for the search of heavy nuetrinos. In addition, its successor NA62 has set new limits on the rate of charged kaon decay into a heavy neutral lepton (HNL) and a lepton, with = e, µ, using the data collected in 2007 and 2015. New limits on heavy neutrinos from kaon decays into pions, muons and positrons are presented in this report.

PhysicsParticle physicsLarge Hadron ColliderMuonPhysics::Instrumentation and Detectors010308 nuclear & particles physicsPhysicsQC1-999Nuclear TheoryHigh Energy Physics::PhenomenologyHeavy neutrino01 natural sciencesSettore FIS/04 - Fisica Nucleare e SubnuclearePhysics and Astronomy (all)Pion0103 physical sciencesHigh Energy Physics::ExperimentKaon decaysNeutrinoHeavy neutrinoNuclear Experiment010306 general physicsKaon decays Heavy neutrinoParticle Physics - ExperimentLepton
researchProduct

Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS IC…

2017

Precision medicine (PM) is increasingly recognized as the way forward for optimizing patient care. Introduced in the field of oncology, it is now considered of major interest in other medical domains like allergy and chronic airway diseases, which face an urgent need to improve the level of disease control, enhance patient satisfaction and increase effectiveness of preventive interventions. The combination of personalized care, prediction of treatment success, prevention of disease and patient participation in the elaboration of the treatment plan is expected to substantially improve the therapeutic approach for individuals suffering from chronic disabling conditions. Given the emerging dat…

allergic rhinitis; integrated care pathway; precision medicine; rhinosinusitisAllergyRhinosinusitisDiseaseAllergic rhinitis0302 clinical medicineQUALITY-OF-LIFEMedicineImmunology and Allergy030223 otorhinolaryngologySinusitisNASAL POLYPOSISRhinitisPrecision medicineintegrated care pathway3. Good healthAlgorithmREAL-LIFEIMPACT OUTCOMESARIA and EPOS working groups1107 ImmunologyDISEASESGA(2)LENDisease Progressionallergic rhinitiLife Sciences & BiomedicineENDOSCOPIC SINUS SURGERYAlgorithmsHumanIntegrated care pathwayallergic rhinitis; integrated care pathway; precision medicine; rhinosinusitis; Adult; Algorithms; Chronic Disease; Disease Progression; Humans; Precision Medicine; Rhinitis Allergic; Sinusitis; Young Adult; Immunology and Allergy; ImmunologyAdultmedicine.medical_specialtyprecision medicineImmunologyrhinosinusitiPHENOTYPESVALIDATIONYoung Adult03 medical and health sciencesTherapeutic approachAllergicPatient satisfactionQuality of life (healthcare)HumansSinusitisPatient participationIMMUNOTHERAPYIntensive care medicinerhinosinusitisAsthmaScience & Technologyallergic rhinitis; integrated care pathway; precision medicine; rhinosinusitis; Immunology and Allergy; Immunologyallergic rhinitisbusiness.industrymedicine.diseasePrecision medicineSinusitiRhinitis AllergicSEVERITY030228 respiratory system3121 General medicine internal medicine and other clinical medicineChronic DiseasePhysical therapyASTHMAbusiness
researchProduct

Neuroimmaging in childhood central nervous system tuberculosis

2006

researchProduct

Infezione da HHV8 e leucemia linfoblastica acuta in età pediatrica

2003

HHV8 è un virus erpetico correlato, sulla base di dati ormai concordi, al sarcoma di Kaposi (KS), al linfoma effusivo primario ed alla Ma- lattia di Castleman multicentrica. Tale virus è stato inoltre associato con altre patologie tumorali ma gli studi in proposito non sono stati confermati. Poco, d’altra parte, si conosce sulle modalità prevalenti di trasmissione del virus, probabilmente diverse nelle nazioni industrializzate ed in quelle in via di sviluppo. In Sicilia una elevata prevalenza del KS clas- sico era già presente in epoca pre-AIDS. Abbiamo condotto uno studio sierologico in immunofluorescenza per rilevare gli anticorpi anti-HHV8 in 40 bambini con leucemia linfoblastica acuta (…

Microbiology (medical)Settore MED/42 - Igiene Generale E ApplicataHuman Herpes virus 8-Leukaemia-Kaposi's sarcoma
researchProduct

Lower apoptosis rate in human cumulus cells, after r-LH administration in ovarian stimulation for IVF procedure

2006

researchProduct

WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Ac…

2017

Gerontologymedicine.medical_specialtybusiness.industryRespiratory diseaseAlternative medicinemedicine.disease03 medical and health sciences0302 clinical medicine030228 respiratory systemGeneral partnershipAction planmedicineGeneral Earth and Planetary Sciences030212 general & internal medicineHealthy ageingbusinessGeneral Environmental ScienceAlergologia Polska - Polish Journal of Allergology
researchProduct

The Design of an Infrastructure for Technology Transfer in Southern Italy - Role of Regional Institutions

1979

Abstract This paper coordinates and integrates the interventions of Proff. G. LO GIUDICE and A. ROMANO, included in the conference programme. It starts mainly from the socio-economical system of Southern Italy, and it consists in the following main points: - analysis of the system features to be interconnected for the development of an infrastructure for developing technological transfer; - ways of understanding the suitability of technologies for Southern Italy; - a proposal for a macro-organizational model for the development of an infrastructure aiming at the technological transfer; - pointing out the role of the”Regioni” and of the direct Government interventions in the innovative proce…

GovernmentEngineeringbusiness.industrymedia_common.quotation_subjectPrincipal (computer security)Regional scienceTechnology transferOperations managementbusinessDutymedia_commonIFAC Proceedings Volumes
researchProduct

Searches for lepton number violating $K^+$ decays

2019

The NA62 experiment at CERN reports a search for the lepton number violating decays K+ -> pi(-)e(+)e(+) and K+ -> pi(-)mu(+)mu(+) using a data sample collected in 2017. No signals are observed, and upper limits on the branching fractions of these decays of 2.2 x 10(-10) and 4.2 x 10(-11) are obtained, respectively, at 90% confidence level. These upper limits improve on previously reported measurements by factors of 3 and 2, respectively.

branching ratio: upper limitK+: rare decayNA62 experiment01 natural sciencesNA62Settore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - Experimentelectron: pair productionHigh Energy Physics - Experiment (hep-ex)EconomicaK+: branching ratio[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]K meson decayPhysicsLarge Hadron ColliderElectroweak interactionlcsh:QC1-999muon: pair productionlepton number violationK+: semileptonic decayK+: secondary beamParticle Physics - ExperimentNuclear and High Energy PhysicsParticle physicsCERN LabS010.46FOS: Physical scienceskaonsS010:Desig=46K+ --> pi- 2muon+Partícules (Física nuclear)PE2_2Violació CP (Física nuclear)0103 physical sciencesKaon decayslepton number violation K meson K meson decay010306 general physicslepton number: violationKaon decays Lepton Number Violationhep-ex010308 nuclear & particles physicsS010:Desig=19CERN SPSK mesonLepton numberK+ --> pi- electron positronKaon Physics; Lepton Flavour Violation; NA62S010.19lcsh:Physicsexperimental results
researchProduct

Search for heavy neutrinos in K + → μ + ν μ decays

2017

The NA62 experiment recorded a large sample of K+→μ+νμ decays in 2007. A peak search has been performed in the reconstructed missing mass spectrum. In the absence of a signal, limits in the range 2×10−6 to 10−5 have been set on the squared mixing matrix element |Uμ4|2 between muon and heavy neutrino states, for heavy neutrino masses in the range 300–375 MeV/ c2 . The result extends the range of masses for which upper limits have been set on the value of |Uμ4|2 in previous production search experiments.

PhysicsNuclear and High Energy PhysicsRange (particle radiation)Particle physicsMuon010308 nuclear & particles physicsPhysics beyond the Standard ModelHeavy neutrinoNA62 experiment01 natural scienceslcsh:QC1-999Heavy neutrinos; Kaon decays; Nuclear and High Energy PhysicsNuclear physicsKaon decayHeavy neutrinos0103 physical sciencesMass spectrumKaon decaysNeutrinoHeavy neutrino010306 general physicslcsh:PhysicsMixing (physics)
researchProduct

Tuberculosis of the central nervous system in children: 32 years survey.

2005

Aim. In order to study the impact of clinical and diagnostic parameters on the clinical outcome of children with central nervous system tuberculosis (CNS-TB), we retrospectively reviewed all cases of CNS-TB diagnosed over a 32-year period at the Children's Hospital of Palermo, Italy. Methods. Data were collected with regard to the clinical, laboratory and demographic characteristics of patients, as well as the results of radiological investigations and data on clinical outcome. In relation to the date of introduction of new diagnostic methods (indirect as well direct) and to the change of treatment periods, the authors compared the clinical outcome of patients admitted prior and after 1984.…

MaleTime FactorsTuberculosis Central Nervous System diagnosis drug therapyTuberculin TestData CollectionAge FactorsAntitubercular AgentsInfantMycobacterium tuberculosisTuberculosis Central Nervous SystemTreatment OutcomeItalyChild PreschoolData Interpretation StatisticalHumansFemaleChildRetrospective StudiesMinerva pediatrica
researchProduct

Overview of the JET results

2015

Since the installation of an ITER-like wall, the JET programme has focused on the consolidation of ITER design choices and the preparation for ITER operation, with a specific emphasis given to the bulk tungsten melt experiment, which has been crucial for the final decision on the material choice for the day-one tungsten divertor in ITER. Integrated scenarios have been progressed with the re-establishment of long-pulse, high-confinement H-modes by optimizing the magnetic configuration and the use of ICRH to avoid tungsten impurity accumulation. Stationary discharges with detached divertor conditions and small edge localized modes have been demonstrated by nitrogen seeding. The differences in…

Chemical analysiMagnetic confinementEdge localized modeTokamak:Física [Ciências exactas e naturais]Nuclear engineeringplasma-facing componentsTungsten7. Clean energyiter-like walllaw.inventionheat loadsAlcator C-ModlawPlasma-facing componentalcator C-MODQCPhysicsJet (fluid)Thermally activatedDivertormagnetic confinementMagnetic confinement fusionTokamak deviceerosionCondensed Matter PhysicsChemical erosionPost mortem analysiCondensed Matter Physics; Nuclear and High Energy PhysicsBerylliumAtomic physicstokamaksTokamaksNuclear and High Energy Physicschemistry.chemical_elementImpurity accumulationCondensed Matter PhysicNuclear and High Energy Physics; Condensed Matter PhysicsTungstenFísica Física:Physical sciences [Natural sciences]divertorNuclear fusionNuclear and High Energy PhysicPhysics Physical sciencesGas fuel analysifuel retentionSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)operationOrders of magnitudechemistryJETtransportMagnetic configuration
researchProduct

Search for heavy neutral lepton production in K+ decays to positrons

2020

A search for heavy neutral lepton ($N$) production in $K^+\to e^+N$ decays using the data sample collected by the NA62 experiment at CERN in 2017--2018 is reported. Upper limits of the extended neutrino mixing matrix element $|U_{e4}|^2$ are established at the level of $10^{-9}$ over most of the accessible heavy neutral lepton mass range 144--462 MeV/$c^2$, with the assumption that the lifetime exceeds 50 ns. These limits improve significantly upon those of previous production and decay searches. The $|U_{e4}|^2$ range favoured by Big Bang Nucleosynthesis is excluded up to a mass of about 340 MeV/$c^2$.

AstrofísicaNuclear and High Energy PhysicsHeavy neutral lepton kaon meson kaon decay positronPontecorvo–Maki–Nakagawa–Sakata matrixSocio-culturaleFOS: Physical sciencesNA62 experiment7. Clean energy01 natural sciencesNA62High Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)Positronkaon decays heavy neutral lepton SM extensionsPE2_2Big Bang nucleosynthesisSM extensionskaon physics0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]010306 general physicsComputingMilieux_MISCELLANEOUSPhysicsRange (particle radiation)Large Hadron Colliderkaon decays010308 nuclear & particles physicshep-exSettore FIS/04Heavy neutral leptonlepton flavour violationFísicalcsh:QC1-999kaon mesonkaon decaykaon physics; lepton flavour violation; NA62positronProduction (computer science)High Energy Physics::Experimentkaonlcsh:PhysicsParticle Physics - ExperimentLepton
researchProduct

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

2015

Accepted Article

AllergyAllergyMedical InformaticSettore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIOWORLD-HEALTH-ORGANIZATIONReviewComorbidityWeb BrowserHealth informatics:Medicina Clínica [Ciências Médicas]ARIA; ICT; MACVIA-LR; allergic rhinitis; asthma; clinical decision support system; conjunctivitis; visual analogue scalevisual analogue scaleQUALITY-OF-LIFEconjunctivitisMedicineImmunology and AllergyDisease management (health)ComputingMilieux_MISCELLANEOUSRhinitisClinical Trials as TopicCLIMATE-CHANGE[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyAllergenHealth PolicyDisease ManagementRANDOMIZED CONTROLLED-TRIAL3. Good healthCHRONIC RESPIRATORY-DISEASESclinical decision support systemINTEGRATED CARE PATHWAYS1107 ImmunologyVISUAL ANALOG SCALESPractice Guidelines as TopicMedical emergencyallergic rhinitiLife Sciences & BiomedicineHumanEUROPEAN INNOVATION PARTNERSHIPImmunologyClinical Decision-MakingSocio-culturaleReproducibility of Resultallergic rhinitis; ARIA; asthma; Information and communications technology; MACVIA-LR; Allergens; Biomarkers; Clinical Decision-Making; Clinical Trials as Topic; Comorbidity; Disease Management; Health Planning; Health Policy; Humans; Medical Informatics; Practice Guidelines as Topic; Reproducibility of Results; Rhinitis Allergic; Web Browser; Immunology and Allergy; ImmunologyInformation and communications technologyClinical decision support systemMACVIA-LRQuality of life (healthcare)AllergicARIA; Information and communications technology; MACVIA-LR; allergic rhinitis; asthmaJournal ArticleHumansCiências Médicas::Medicina ClínicaAsthmaScience & Technologyallergic rhinitisARIAbusiness.industrySettore MED/09 - MEDICINA INTERNAReproducibility of ResultsGuidelineBiomarkerta3121Allergensasthmamedicine.diseaseRhinitis AllergicIntegrated careHealth PlanningPOLLEN COUNTSICTallergic rhinitis; ARIA; asthma; Information and communications technology; MACVIA-LR; Allergens; Biomarkers; Clinical Decision-Making; Clinical Trials as Topic; Comorbidity; Disease Management; Health Planning; Health Policy; Humans; Medical Informatics; Practice Guidelines as Topic; Reproducibility of Results; Rhinitis Allergic; Web BrowserImmunologybusinessDECISION-SUPPORT-SYSTEMSBiomarkersMedical Informatics[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

2021

Abstract Background Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results NNVs were more favourable in su…

MaleCOVID-19 Vaccinesafe surgery; vaccination modelling; COVID-19Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]MULTICENTERComorbidity030230 surgery0302 clinical medicinephase 3 clinical trial (topic)Case fatality rateProspective StudiesSARS-CoV-2 Vaccination Safe surgeryCOVID-19/epidemiologySARS-CoV-2 ; vaccination ; safe surgeryeducation.field_of_studycase fatality rateVaccinationVaccinationAdolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Postoperative Complications; Preoperative Period; Prospective Studies; SARS-CoV-2; Vaccination; Young Adulthealth care policyElective Surgical Procedures030220 oncology & carcinogenesisvaccination modellingPreoperative PeriodCOVID-19; SARS-CoV-2; cancer; vaccination; outcome; mortality; infection; modellingCohort studyprospective studyHumanmedicine.medical_specialtyArticle03 medical and health sciencesSARS-CoV-2 vaccinationSDG 3 - Good Health and Well-beingCOVID-19 Vaccines/pharmacologyHumansVaccination/methodsElective surgeryeducationAgedScience & TechnologyElective Surgical Procedureadult; aged; Article; cancer grading; cancer surgery; case fatality rate; computer assisted tomography; elective surgery; female; follow up; health care policy; human; incidence; infection rate; infection risk; major clinical study; male; middle aged; mortality; outcome assessment; phase 3 clinical trial (topic); preoperative care; prospective study; sensitivity analysis; seroprevalence; Severe acute respiratory syndrome coronavirus 2; vaccination; young adult; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Postoperative Complications; Preoperative Period; SARS-CoV-2; Vaccination; surgery.Cura preoperatòriamajor clinical studymortalityinfectionProspective StudieincidenceSurgeryHuman medicinePostoperative Complication610 Medizin und GesundheitAcademicSubjects/MED00910Settore MED/18 - CHIRURGIA GENERALESettore MED/29 - CHIRURGIA MAXILLOFACCIALEcomputer assisted tomographyESTUDOS PROSPECTIVOSsurgerysafe surgeryPostoperative Complicationssensitivity analysisSevere acute respiratory syndrome coronavirus 2preoperative careVacunacióProspective cohort studyseroprevalenceIncidence (epidemiology)covidElective Surgical Procedures/methodsMiddle Agedcancer gradingCOVID vaccinationoutcome/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSARS-CoV-2; vaccination; surgeryOriginal ArticleFemalecancer surgeryAcademicSubjects/MED00010Life Sciences & BiomedicineAdultCOVID-19 VaccinesAdolescentinternational prospective cohort studyPostoperative Complications/prevention & controlPopulationinfection rateSARS-CoV-2/immunologyNOmodellingYoung Adultmedicinefollow upcancerddc:610infection riskoutcome assessmentLS7_4business.industrySARS-CoV-2Number needed to vaccinatePreoperative careCOVID-193126 Surgery anesthesiology intensive care radiologySettore MED/18Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]elective surgeryEmergency medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyThe British Journal of Surgery
researchProduct

Apoptosis in Human Cumulus Cells

2006

researchProduct

Search for K+→ π+νν¯ at NA62

2018

Flavour physics is one of the most powerful fields for the search of new physics beyond the Standard Model. The kaon sector with the rare decay K+ → π+νν̅ provides one of the cleanest and most promising channels. NA62, a fixed target experiment at the CERN SPS, aims to measure BR (K+ → π+νν̅) with 10% precision to test the Standard Model validity up to an energy scale of hundreds of TeV. NA62 had dedicated data taking for the K+ → π+νν̅ measurement in 2016 and 2017 and will continue in 2018. Here preliminary results on a fraction of 2016 dataset are presented. The analysis of the complete 2016 data sample is expected to achieve the SM sensitivity.

PhysicsParticle physicsLarge Hadron Collider010308 nuclear & particles physicsPhysics beyond the Standard ModelPhysicsQC1-999Flavour Physicsrare Kaon decays01 natural sciencesMeasure (mathematics)Settore FIS/04 - Fisica Nucleare e SubnucleareStandard ModelPhysics and Astronomy (all)0103 physical sciences010306 general physicsFlavour Physics rare Kaon decays
researchProduct

NA48/62 latest results

2017

The NA62 experiment at the CERN SPS recorded in 2007 a large sample of K+ ? µ+?µ decays. A peak search in the missing mass spectrum of this decay is performed. In the absence of observed signal, the limits obtained on B(K+ ? µ+?h) and on the mixing matrix element |Uµ 4| are reported. The upgraded NA62 experiment started data taking in 2015. About 5×1011K+ decays have been recorded so far to measure the branching ratio of the K+ ? ?+?? decay. Preliminary results from the K+ ? ?+?? analysis based on about 5% of the 2016 statistics are reported.

Nuclear physicsPhysicsParticle physicsBranching fractionTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITYMass spectrumMatrix elementCreative commonsNA62 experimentParticle Physics - ExperimentSettore FIS/04 - Fisica Nucleare e SubnucleareLarge sample
researchProduct

MOESM1 of Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Act…

2016

Additional file 1. IPCRG scaling up activities.

researchProduct

Physics requirements for the VUV survey spectrometer intended for the divertor radiation monitoring on JT-60SA

2019

JT-60SA is a fusion experiment designed to support the operation of ITER and to investigate how best to optimize the operation of future fusion power plants. For the safe operation of the device, a survey spectrometer observing the plasma from an equatorial port is foreseen to monitor light impurities such as carbon and oxygen, metal impurities and extrinsic impurities injected ad hoc to mitigate the power exhaust problem. A second survey spectrometer, to be designed and constructed within the presented work, positioned on an upper port with a vertical line of sight, will complement the monitoring activity of the first system by measuring the relative contribution of the various impurities …

VUV survey spectrometerITERJT-60SA
researchProduct

Platelet activation markers in long-term follow-up of young subjects with acute myocardial infarction

2006

Beta-thromboglobulinPlatelet factor 4.Ischemic heart disease
researchProduct

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B…

2016

Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organizatio…

Pulmons -- Malalties obstructivesVeterinary medicineAllergyPublished ErratumLANGUEDOC-ROUSSILLONAllergyRespiratory Medicine and Allergy[SDV]Life Sciences [q-bio]Aparell respiratori -- MalaltiesOPERATIONAL DEFINITIONAlternative medicineReviewChronic respiratory diseasesGLOBAL ALLIANCESYSTEMS MEDICINE0302 clinical medicineMedicine and Health SciencesImmunology and AllergyMACVIA030212 general & internal medicineAIRWAYS ICPLungmedicin och allergiEIP on AHA; European Innovation Partnership on Active and Healthy Ageing; Chronic respiratory diseases; AIRWAYS ICPs; MACVIA; ARIA; Scaling upGINA STRATEGYAIRWAYSUPDATE ARIA 2008Scaling upRespiratory disease:Outras Ciências Agrárias [Ciências Agrárias]3. Good healthChronic respiratory diseaseALLERGIC RHINITISICPsAIRWAYS ICPsGeneral partnershipAction planErratumLife Sciences & BiomedicineAIRWAYS ICPs; ARIA; Chronic respiratory diseases; EIP on AHA; European Innovation Partnership on Active and Healthy Ageing; MACVIA; Scaling upPulmonary and Respiratory Medicinemedicine.medical_specialtyEIP on AHAAIRWAYS ICPs; ARIA; Chronic respiratory diseases; EIP on AHA; European Innovation Partnership on Active and Healthy Ageing; MACVIA; Scaling up; Immunology and AllergyEmerging technologiesImmunologyREFERENCE SITESocio-culturalePredictive medicine03 medical and health sciencesEuropean Innovation Partnership on Active and Healthy AgeingNursingCritical success factorJournal Articlemedicineddc:610Science & TechnologyARIAbusiness.industrySettore MED/09 - MEDICINA INTERNAAIRWAYS-ICPSmedicine.diseaseIntegrated careAlliance030228 respiratory systemCiências Agrárias::Outras Ciências Agrárias3121 General medicine internal medicine and other clinical medicineFamily medicineImmunologyHealthy ageingbusinessSEVERE ASTHMA
researchProduct

Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

2016

The authors would like to change and use the correct name of M. Khaitov which is M. Kaitov on this manuscript. The authors have incorrectly used her other name during the finalization of this research. With this, the authors hereby publish the correct author names as presented above. © 2016 Serdi and Springer-Verlag France

Nutrition and DieteticsNutrition & DieteticsGeriatrics gerontologybusiness.industryMedicine (miscellaneous)Settore MED/10 - Malattie Dell'Apparato RespiratorioallergyFinalizationAsthmaAction (philosophy)Correct nameMedicineEngineering ethicsGeriatrics and GerontologybusinessQuality of Life Research
researchProduct

Simulation of the VUV spectral emission from the JT-60SA divertor

2021

A divertor survey dual-spectrometer is being designed by an EU-Japan team [1] to be installed on JT-60SA [2], the new fusion experiment expected to start operating in 2020. Positioned on an upper port, the primary role of the spectrometer is to analyse the radiation losses in the divertor region and to aid studying the physics of the divertor plasmas, including plasma detachment. Its spatial resolution capability is around 10 cm at the divertor and its two branches together cover the wavelength range from 10 to 130 nm, to satisfy the physics scope [3]. The spectrometer Lines Of Sight (LOS) are mapped onto a 2D SOLEDGE [4] simulations of the divertor region carried out for different density …

VUV spectrometerVUV spectral emissionJT-60SA divertorJT-60SA
researchProduct

Search for heavy neutral lepton production in K+ decays

2018

A search for heavy neutral lepton production in $K^+$ decays using a data sample collected with a minimum bias trigger by the NA62 experiment at CERN in 2015 is reported. Upper limits at the $10^{-7}$ to $10^{-6}$ level are established on the elements of the extended neutrino mixing matrix $|U_{\ell 4}|^2$ ($\ell=e,\mu$) for heavy neutral lepton mass in the range $170-448~{\rm MeV}/c^2$. This improves on the results from previous production searches in $K^+$ decays, setting more stringent limits and extending the mass range.

Nuclear and High Energy PhysicsleptonPontecorvo–Maki–Nakagawa–Sakata matrixheavy neutral leptons neutrino mixingFOS: Physical sciencesk mesonNA62 experiment01 natural sciencesneutrino mixingSettore FIS/04 - Fisica Nucleare e SubnuclearedecayHigh Energy Physics - ExperimentNuclear physicsneutrinoHigh Energy Physics - Experiment (hep-ex)Minimum biasEconomicaBounds; neutrinos; masses; testsTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY0103 physical sciencesheavy neutral leptonslepton k meson decay neutrino010306 general physicsNuclear ExperimentPhysicsRange (particle radiation)Large Hadron Collider010308 nuclear & particles physicshep-exHigh Energy Physics::PhenomenologyAmbientalelcsh:QC1-999High Energy Physics::Experimentlcsh:PhysicsParticle Physics - ExperimentLepton
researchProduct

Polymorphonuclear leukocyte integrin pattern expression in atherosclerosis and diabetes

2004

researchProduct

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

2016

The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA-disseminated and implemented in over 70 countries globally-is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA (Contre les Maladies Chroniques pour un Vieillissement Actif)-ARIA Sentinel NetworK] uses mobile technology to develop care p…

PediatricsAIRWAYS ICPs; ARIA; EIP on AHA; ICT; Mobile technology; Rhinitis; Immunology and AllergyIMPACTHay feverRespiratory Medicine and AllergyDiseaseReview[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract0302 clinical medicineQUALITY-OF-LIFEHDE ALERHealth careMedicine and Health SciencesPERSISTENT ALLERGIC RHINITISMedicineImmunology and Allergy030212 general & internal medicine[SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/AllergologyAIRWAYS ICPComputingMilieux_MISCELLANEOUSRhinitiAIRWAYS ICPs; ARIA; EIP on AHA; ICT; Mobile technology; RhinitisLungmedicin och allergiRhinitisPublic Health Global Health Social Medicine and Epidemiology3. Good healthREAL-LIFEAIRWAYS ICPsARIA; Rhinitis; ICT; EIP on AHA; Mobile technology; AIRWAYS ICPsHay feverCLINICAL-PRACTICE GUIDELINESHEALTHPulmonary and Respiratory Medicinemedicine.medical_specialtyEIP on AHAEUROPEAN INNOVATION PARTNERSHIPImmunologySocio-culturaleClinical decision support systemICT; EIP on AHAPredictive medicine03 medical and health sciencesQuality of life (healthcare)Mobile technologyJournal ArticleMobile technologyAsmaAsthmaScience & TechnologyARIAbusiness.industryAIRWAYS ICPs; ARIA; EIP on AHA; ICT; Mobile technology; Rhinitis;Settore MED/09 - MEDICINA INTERNAAIRWAYS-ICPSCorrectionmedicine.disease2008 UPDATEFebre del fencAsthmaFolkhälsovetenskap global hälsa socialmedicin och epidemiologi030228 respiratory systemFamily medicineICTVISUAL ANALOG SCALEbusiness
researchProduct

Overview of the JET results with the ITER-like wall

2013

Following the completion in May 2011 of the shutdown for the installation of the beryllium wall and the tungsten divertor, the first set of JET campaigns have addressed the investigation of the retention properties and the development of operational scenarios with the new plasma-facing materials. The large reduction in the carbon content (more than a factor ten) led to a much lower Zeff (1.2-1.4) during L- and H-mode plasmas, and radiation during the burn-through phase of the plasma initiation with the consequence that breakdown failures are almost absent. Gas balance experiments have shown that the fuel retention rate with the new wall is substantially reduced with respect to the C wall. T…

Nuclear and High Energy PhysicsMaterials scienceREGIMENuclear engineeringchemistry.chemical_element-Condensed Matter PhysicEffective radiated powerTungstenNuclear and High Energy Physics; Condensed Matter PhysicsPedestalPLASMA-FACING COMPONENTSTOKAMAK PLASMASJet (fluid)TUNGSTENDivertorperfomancePlasmaPERFORMANCECondensed Matter PhysicsSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)chemistryBeta (plasma physics)DIVERTORBerylliumAtomic physics
researchProduct

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

2019

AIMS: Mobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life cycle, whatever their gender or socio-economic status, in order to reduce health and social inequities incurred by the disease and to improve the digital transformation of health and care. The ultimate goal is to change the management strategy in chronic diseases. METHODS: MASK implements ICT technologies for individualized and predictive medicine to develop novel care pathways by a multi-disciplinary group centred around the patients. STAKEHOLDERS: Incl…

SENTINEL NETWORKAllergyRespiratory Medicine and AllergyReviewWORLD-HEALTH-ORGANIZATIONDiseaseRhinitis.App; Asthma; Care pathways; DG Santé; MASK; mHealth; Rhinitis0302 clinical medicineQUALITY-OF-LIFEPRECISION MEDICINEDG SantéHealth careMedicine and Health SciencesGRADING QUALITYImmunology and AllergyMedicinemHealthRinitisLungmedicin och allergiRhinitis0303 health sciencesThe MASK study groupPublic sectorApp ; Asthma ; Care pathways ; MASK ; mHealth ; Rhinitis ; DG SanteMOBILE TECHNOLOGY3. Good healthALLERGIC RHINITISCHRONIC RESPIRATORY-DISEASESRinitemHealthCare pathwaysEUROPEAN SYMPOSIUMCLINICAL-PRACTICE GUIDELINESLife Sciences & BiomedicinePulmonary and Respiratory Medicinemedicine.medical_specialtyMASKImmunologySettore MED/10 - Malattie Dell'Apparato RespiratorioPredictive medicine03 medical and health sciencesQuality of life (healthcare)App -MASKAsma030304 developmental biologyAsthmaARIAScience & TechnologyCare pathwaybusiness.industryChange managementCorrectionDG SanteRC581-607medicine.diseaseAsthma030228 respiratory systemApp; Asthma; Care pathways; DG Santé; MASK; mHealth; Rhinitis; Immunology and Allergy; Immunology; Pulmonary and Respiratory MedicineFamily medicineImmunologic diseases. AllergybusinessApp[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Search for Lepton Number and Flavor Violation in K+ and π0 Decays

2021

Searches for the lepton number violating $K^{+} \rightarrow \pi^{-} \mu^{+} e^{+}$ decay and the lepton flavour violating $K^{+} \rightarrow \pi^{+} \mu^{-} e^{+}$ and $\pi^{0} \rightarrow \mu^{-} e^{+}$ decays are reported using data collected by the NA62 experiment at CERN in $2017$-$2018$. No evidence for these decays is found and upper limits of the branching ratios are obtained at 90% confidence level: $\mathcal{B}(K^{+}\rightarrow\pi^{-}\mu^{+}e^{+})<4.2\times 10^{-11}$, $\mathcal{B}(K^{+}\rightarrow\pi^{+}\mu^{-}e^{+})<6.6\times10^{-11}$ and $\mathcal{B}(\pi^{0}\rightarrow\mu^{-}e^{+})<3.2\times 10^{-10}$. These results improve by one order of magnitude over previous results for thes…

PhysicsParticle physics010308 nuclear & particles physicsBranching fractionHigh Energy Physics::PhenomenologyFlavourGeneral Physics and Astronomy01 natural sciencesLepton number0103 physical sciencesPiHigh Energy Physics::Experiment010306 general physicsLeptonPhysical Review Letters
researchProduct

Study of the K±→π±γγ decay by the NA62 experiment

2014

Abstract A study of the dynamics of the rare decay K ± → π ± γ γ has been performed on a sample of 232 decay candidates, with an estimated background of 17.4 ± 1.1 events, collected by the NA62 experiment at CERN in 2007. The results are combined with those from a measurement conducted by the NA48/2 Collaboration at CERN. The combined model-independent branching ratio in the kinematic range z = ( m γ γ / m K ) 2 > 0.2 is B MI ( z > 0.2 ) = ( 0.965 ± 0.063 ) × 10 − 6 , and the combined branching ratio in the full kinematic range assuming a Chiral Perturbation Theory description is B ( K π γ γ ) = ( 1.003 ± 0.056 ) × 10 − 6 . A detailed comparison of the results with the previous measurements…

PhysicsNuclear and High Energy PhysicsParticle decayPionChiral perturbation theoryNuclear magnetic resonanceMesonBranching fractionHadronAnalytical chemistryElementary particleDimensionless quantityPhysics Letters B
researchProduct

Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.

2017

The Strategic Implementation Plan of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) proposed six Action Groups. After almost three years of activity, many achievements have been obtained through commitments or collaborative work of the Action Groups. However, they have often worked in silos and, consequently, synergies between Action Groups have been proposed to strengthen the triple win of the EIP on AHA. The paper presents the methodology and current status of the Task Force on EIP on AHA synergies. Synergies are in line with the Action Groups' new Renovated Action Plan (2016-2018) to ensure that their future objectives are coherent and fully connected. The …

AgingProcess managementGeriatrics & GerontologyEuropean Innovation Partnership on Active and Healthy Ageing polypharmacy education falls frailty integrated care citizen empowerment chronic respiratory diseasesHealth BehaviorChronic respiratory diseasesPARTNERSHIPCoaching[SHS]Humanities and Social Sciences0302 clinical medicineSurveys and Questionnaires80 and overMedicineCooperative BehaviorComputingMilieux_MISCELLANEOUSInterventionsmedia_commonintegrated careAged 80 and over:Enginyeria biomèdica [Àrees temàtiques de la UPC]Multiple Chronic ConditionOrganizational Innovation3. Good healthCHRONIC RESPIRATORY-DISEASESHealthAction planGeneral partnershipFallsHEALTHPartnershipINTERVENTIONSHumanmedia_common.quotation_subjectfallFrail ElderlyEuropean Continental Ancestry GroupBioengineeringWhite PeopleEducation03 medical and health sciencesEUROPEAN-UNIONActive and Healthy Ageingmedia_common.cataloged_instanceHumansBioenginyeriaEuropean unionAgedScience & TechnologyNutrition & DieteticsPreventionPREVENTIONCitizen empowerment030228 respiratory systemAction (philosophy)European Innovation Partnership on Active and Healthy Ageing; polypharmacy; education; falls; frailty; integrated care; citizen empowerment; chronic respiratory diseases; Accidental Falls; Aged; Aged 80 and over; Chronic Disease; Cooperative Behavior; Europe; Frail Elderly; Humans; Multiple Chronic Conditions; Organizational Innovation; Polypharmacy; Surveys and Questionnaires; Aging; European Continental Ancestry Group; Health BehaviorGeriatrics and GerontologyGerontologySettore MED/09 - Medicina Interna[SDV]Life Sciences [q-bio]OPERATIONAL DEFINITIONEMPOWERMENTMedicine (miscellaneous)Medicine (miscellaneous); Nutrition and Dietetics; Geriatrics and GerontologyChronic respiratory-diseasesAllergic rhinitisQUALITY-OF-LIFEEuropean-UnionNutrition and DieteticSurveys and Questionnaire030212 general & internal medicineMultiple Chronic ConditionsEmpowermenteducationNutrition and DieteticsFrailtyAccidental FallIntegrated careALLERGIC RHINITISEuropeSettore MED/42EmpowermentLife Sciences & BiomedicinefrailtyEuropean Innovation Partnership on Active and Healthy AgeingJournal ArticleMETIS-318216IR-101708Responsible Research and Innovationbusiness.industrychronic respiratory diseaseIntegrated careOperational definition3121 General medicine internal medicine and other clinical medicineChronic DiseasePolypharmacycitizen empowermentAccidental Fallschronic respiratory diseases; citizen empowerment; education; European Innovation Partnership on Active and Healthy Ageing; falls; frailty; integrated care; polypharmacy; Medicine (miscellaneous); Nutrition and Dietetics; Geriatrics and GerontologyQuality-of-lifebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyThe journal of nutrition, healthaging
researchProduct

Test of lepton flavour universality in K+→ℓ+ν decays

2011

Abstract A precision test of lepton flavour universality has been performed by measuring the ratio R K of kaon leptonic decay rates K + → e + ν and K + → μ + ν in a sample of 59 813 reconstructed K + → e + ν candidates with ( 8.71 ± 0.24 ) % background contamination. The result R K = ( 2.487 ± 0.013 ) × 10 − 5 is in agreement with the Standard Model expectation.

Nuclear physicsPhysicsNuclear and High Energy PhysicsParticle physicsFlavourWidth ratioUniversality (dynamical systems)LeptonPhysics Letters B
researchProduct

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile techn…

2019

Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second c…

AllergyAllergy:Medicina Básica [Ciências Médicas]asthma -- guidelineAllergic asthmaDECISION-MAKINGAllergic Rhinitis and Its Impact on AsthmaGUIDELINESMedical and Health SciencesMedical Records0302 clinical medicineHealth careImmunology and Allergy030212 general & internal medicineAllergic Rhinitis and Its Impact on Asthma; asthma; Change management; rhinitis; Immunology and Allergy; ImmunologyMASK-RHINITISComputingMilieux_MISCELLANEOUSRinitismobilne aplikacijeupravljanje spremembMedical recordGLOBAL STRATEGYWORK PRODUCTIVITYTelemedicinemobile applications3. Good healthAsma alérgicarhiniti1107 ImmunologyCiências Médicas::Medicina Básicaklinične potiallergic -- guidelineLife Sciences & BiomedicineHumanPATIENT PARTICIPATIONAllergic RhinitisTelemedicinemedicine.medical_specialtyanimal structuresmultimorbidityEUROPEAN INNOVATION PARTNERSHIPImmunologyChange Management[object Object]Settore MED/10 - Malattie Dell'Apparato RespiratorioAsthma/diagnosisCHRONIC DISEASESMACVIA-ARIA03 medical and health sciencesrhinitismedicinemultimorbidnostQUALITYHumanscritical pathwaysastma -- smernicaPatient participationAsmaudc:616.2AsthmaScience & TechnologyARIAbusiness.industryAllergic Rhinitis and Its Impact on Asthma; asthma; Change management; rhinitis; Change Management; Humans; Medical Records; Asthma; Multimorbidity; Rhinitis Allergic; TelemedicineSettore MED/09 - MEDICINA INTERNAchange managementMultimorbidityMobile Airways Sentinel Network (MASK) Study GroupGuidelineasthmata3121medicine.diseaseRinite alérgicaRhinitis AllergicRhinitis Allergic/diagnosisAsthmaIntegrated carealergijski rinitis -- smernicaAllergic Rhinitis and Its Impact on Asthma asthma Change management rhinitis Immunology and Allergy Immunology030228 respiratory systemFamily medicine3121 General medicine internal medicine and other clinical medicineMedical RecordClinical Medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyImpact on AsthmaJournal of Allergy and Clinical Immunology
researchProduct

Diagnostic problems and postnatal follow-up in congenital toxoplasmosis

2007

Aim. In order to assess the consequences of different clinica] approaches in the prenata] management of congenital toxoplasmosis, we retrospectively reviewed 58 pregnant women with Toxoplasma seroconversion and prospec­ tively enrolled their 59 infants, referred to us from 1999 to 2004. Metbods. Data on clinica!, laboratocy and de­ mographic characteristics of the pregnant women were collected. Their children were entered intoa 48-month follow-up progcamme in which clinica , instrumental, ophthalmo­ logic and serologic evaluations were carried out at birth, at 1, 3, 6, 9, 15, 18, 24, 36 and at 48 months of life. Paediatric treatment with Spiramycin alone or alternated with Pyrime­ thamine-S…

AdultAdolescentSettore MED/17 - Malattie InfettiveAntiprotozoal AgentsSulfadiazinePolymerase Chain ReactionToxoplasmosis CongenitalAntimalarialsPregnancyAnimalsHumansProspective StudiesSicilyRetrospective StudiesInfantToxoplasmosis Diagnostic stepsInfectious Disease Transmission VerticalPyrimethamineTreatment OutcomeImmunoglobulin MImmunoglobulin GPregnancy Complications ParasiticAmniocentesisCoccidiostatsDrug Therapy CombinationFemalePregnancy TrimestersBiomarkersFollow-Up Studies
researchProduct

Precision measurement of the ratio of the charged kaon leptonic decay rates

2013

A precision measurement of the ratio RK of the rates of kaon leptonic decays K+- --&gt; e nu and K+- --&gt; mu nu with the full data sample collected by the NA62 experiment at CERN in 2007-2008 is reported. The result, obtained by analysing ~150000 reconstructed K+- --&gt; e nu candidates with 11% background contamination, is RK = (2.488+-0.010)*10^{-5}, in agreement with the Standard Model expectation.

Nuclear and High Energy PhysicsParticle physicsstandard modelFOS: Physical sciencesNA62 experiment01 natural sciencesHigh Energy Physics - ExperimentStandard ModelNuclear physicsHigh Energy Physics - Experiment (hep-ex)lepton universalityRare kaon decays; chiral perturbation theoryLepton universality; Charged Kaon Decay0103 physical scienceskaon decays leptonic decays lepton universality010306 general physicschiral perturbation theoryPhysicsleptonic decaysLarge Hadron Colliderkaon decays010308 nuclear & particles physicscharged kaon3. Good healthCharged Kaon DecayRare kaon decaysKaon rare decaysFull dataKaon rare decays; branching ratio; charged kaon; leptonic decays; standard modelbranching ratioParticle Physics - ExperimentLepton universality
researchProduct